Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
gene therapy
sarepta therapeutics
allergan
amgen
cystic fibrosis
deals
drugs
duchenne muscular dystrophy
eli lilly
spark therapeutics
teva pharmaceutical
What
drugs
4
×
fda
4
×
bio
roundup
drug
news
won
ahead
approval
aren’t
arguments
asco
august
big
biotech
branded
busy
choices
class
commercialized
commissioner
companies
competitors
consumers
costly
counterweight
days
decades
decisions
developers
devices
elevatebio
gene
generic
graft
help
imminent
legacy
long
make
Language
unset
Current search:
xconomy.com
×
drugs
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
